Literature DB >> 26398076

Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.

James Larkin, F Stephen Hodi, Jedd D Wolchok.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26398076     DOI： 10.1056/NEJMc1509660

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  309 in total

Review 1.  Metastatic melanoma and immunotherapy.

Authors:  Benjamin Herzberg; David E Fisher
Journal:  Clin Immunol       Date:  2016-07-16       Impact factor: 3.969

2.  Untangling the Multidisciplinary Care Web: Streamlining Care Through an Immune-Related Adverse Events (IRAE) Tumor Board.

Authors:  Laura C Kennedy; Kit Man Wong; Nikhil V Kamat; Ali Raza Khaki; Shailender Bhatia; John A Thompson; Petros Grivas
Journal:  Target Oncol       Date:  2020-08       Impact factor: 4.493

Review 3.  Cardiac MRI for the evaluation of oncologic cardiotoxicity.

Authors:  Adrián I Löffler; Michael Salerno
Journal:  J Nucl Cardiol       Date:  2018-05-07       Impact factor: 5.952

4.  Melanoma vaccines: clinical status and immune endpoints.

Authors:  Deena M Maurer; Lisa H Butterfield; Lazar Vujanovic
Journal:  Melanoma Res       Date:  2019-04       Impact factor: 3.599

5.  Endocrine-Related Adverse Events Related to Immune Checkpoint Inhibitors: Proposed Algorithms for Management.

Authors:  Jaydira Del Rivero; Lisa M Cordes; Joanna Klubo-Gwiezdzinska; Ravi A Madan; Lynnette K Nieman; James L Gulley
Journal:  Oncologist       Date:  2019-10-10

6.  Dendritic cell vaccine induces antigen-specific CD8+ T cells that are metabolically distinct from those of peptide vaccine and is well-combined with PD-1 checkpoint blockade.

Authors:  Koji Nagaoka; Akihiro Hosoi; Tamaki Iino; Yasuyuki Morishita; Hirokazu Matsushita; Kazuhiro Kakimi
Journal:  Oncoimmunology       Date:  2017-11-20       Impact factor: 8.110

Review 7.  Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches.

Authors:  Daniela Femia; Natalie Prinzi; Andrea Anichini; Roberta Mortarini; Federico Nichetti; Francesca Corti; Martina Torchio; Giorgia Peverelli; Filippo Pagani; Andrea Maurichi; Ilaria Mattavelli; Massimo Milione; Nice Bedini; Ambra Corti; Maria Di Bartolomeo; Filippo de Braud; Sara Pusceddu
Journal:  Target Oncol       Date:  2018-10       Impact factor: 4.493

8.  Diagnosis and Management of Immune Checkpoint Inhibitor-Associated Neurologic Toxicity: Illustrative Case and Review of the Literature.

Authors:  Kerry L Reynolds; Amanda C Guidon
Journal:  Oncologist       Date:  2018-11-27

Review 9.  Epigenetic mechanisms of tumor resistance to immunotherapy.

Authors:  Natalia Arenas-Ramirez; Dilara Sahin; Onur Boyman
Journal:  Cell Mol Life Sci       Date:  2018-08-23       Impact factor: 9.261

Review 10.  Immunotherapy for advanced thyroid cancers - rationale, current advances and future strategies.

Authors:  Jena D French
Journal:  Nat Rev Endocrinol       Date:  2020-08-24       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.